Screening for esophageal varices in cirrhotic patients: endoscope, platelet count, or both?

Gastrointestinal Endoscopy

Volumn 64, Issue 6, 2006, Pages 865-867

  Charuworn, Prista ^a   Cheung, Ramsey ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER;

BLEEDING; DRUG EFFICACY; EDITORIAL; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPE; GASTROINTESTINAL ENDOSCOPY; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; PATIENT SELECTION; PORTAL HYPERTENSION; PREDICTION; PRESSURE GRADIENT; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCREENING; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; LIVER CIRRHOSIS; PLATELET COUNT;

EID: 33751412779     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.08.033     Document Type: Editorial

References (17)

1. D'Amico G., De Franchis R., and Cooperative Study Group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
2. Jensen D.M. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122 (2002) 1620-1630
3. Chalasani N., Imperiale T.F., Ismail A., et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 94 (1999) 3285-3291
4. D'Amico G., and Morabito A. Non-invasive markers of esophageal varices: another round, not the last. Hepatology 39 (2004) 30-34
5. Dell'era A., and Bosch J. Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding. Aliment Pharmacol Ther 20 3 Suppl (2004) 8-15
6. North-Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 319 (1988) 983-989
7. Giannini E., Botta F., Borro P., et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 98 (2003) 2516-2520
8. Spiegel B.M.R., Targownik L., Dulai G.S., et al. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective?. Hepatology 37 (2003) 366-377
9. Sanyal A.J., Fontana R.J., Di Bisceglie A.M., et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 64 (2006) 855-864
10. Zein C.O., Lindor K.D., and Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology 39 (2004) 203-209
11. Dienstag J.L., and McHutchison J.G. AGA technical review on the management of hepatitis C. Gastroenterology 130 (2006) 231-264
12. Merli M., Nicolini G., Angeloni S., et al. Incidence and natural history of small oesphageal varices in cirrhotic patients. J Hepatol 38 (2003) 266-272
13. Arguedas M.R., Heudebert G.R., Eloubeidi M.A., et al. Cost-effective of screening, surveillance and primary prophyaxis strategies for esophageal varices. Am J Gastreoenterol 97 (2002) 2441-2452
14. De Franchis R. Evolving consensus in portal hypertension: report of Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
15. Lebrec D., Vinel J.-P., and Dupas J.-L. Complications of portal hypertension in adults: a French consensus. Eur J Gastroenterol Hepatol 17 (2005) 403-410
16. American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc 62 (2005) 651-655
17. Grace N.D., Croszman R.J., Garcia-Tsao G., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28 (1998) 868-880